NCT02925338 National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life Status COMPLETED Phase N/A
NCT02924584 Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan Status COMPLETED Phase N/A
NCT02923791 A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product. Status COMPLETED Phase PHASE1
NCT02922192 Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis Status COMPLETED Phase N/A
NCT02922179 Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics Status COMPLETED Phase N/A
NCT02921477 Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias Status ENROLLING_BY_INVITATION Phase PHASE1
NCT02921126 Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy Status COMPLETED Phase N/A
NCT02920450 Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002) Status TERMINATED Phase PHASE1/PHASE2
NCT02918968 Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE4
NCT02915523 Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02912650 A Safety And Efficacy Study of Ibuprofen 250 mg / Acetaminophen 500 mg In The Treatment Of Post-Surgical Dental Pain Status COMPLETED Phase PHASE3
NCT02912572 Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02907918 Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer Status TERMINATED Phase PHASE2
NCT02907619 An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy Status TERMINATED Phase PHASE2
NCT02906696 Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure Status TERMINATED Phase PHASE2
NCT02905318 Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02897375 Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02896335 Palbociclib and Pembrolizumab In Central Nervous System Metastases Status RECRUITING Phase PHASE2